Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Turning wet overnight into Tuesday. Further rain or showers for the rest of the week. Kerrie has the latest....
The Manchester bookkeeper has been jailed after syphoning more than £100,000 from a solicitors firm.
A gang who flooded the streets of Blackpool with Class A drugs and preyed on the vulnerable has been jailed for a total of almost 66 years.